Neuland Laboratories

Neuland Laboratories Current Assets

The Current Assets of Neuland Laboratories (NEULANDLAB.NS) as of Oct 18, 2026 is 9.42 B INR. In the previous year, Current Assets was 11.77 B INR — a change of -19.99% (lower).

Current Assets

9.42 BINR

YoY

-19.99%

Last updated:

Current Assets of Neuland Laboratories is 2026 9.42 B INR. Current Assets of Neuland Laboratories was 2025 11.77 B INR. It decreases by -19.99% lower compared to the previous year.

The Neuland Laboratories Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
5.05 B INR
Jan 1, 2020
5.40 B INR
Jan 1, 2021
5.85 B INR
Jan 1, 2022
6.12 B INR
Jan 1, 2023
7.86 B INR
Jan 1, 2024
9.65 B INR
Jan 1, 2025
11.77 B INR
Jan 1, 2026
9.42 B INR
The Neuland Laboratories Current Assets history
YEARCurrent AssetsYoY
9.42 BINR-19.99%
11.77 BINR+21.99%
9.65 BINR+22.80%
7.86 BINR+28.46%
6.12 BINR+4.61%
5.85 BINR+8.28%
5.40 BINR+7.01%
5.05 BINR+4.32%
4.84 BINR+21.33%
3.99 BINR+11.72%
3.57 BINR-5.27%
3.77 BINR+15.96%
3.25 BINR+41.87%
2.29 BINR+2.16%
2.24 BINR-4.45%
2.35 BINR+14.92%
2.04 BINR+7.70%
1.90 BINR+14.99%
1.65 BINR+21.38%
1.36 BINR+141.34%
562.63 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Neuland Laboratories Stock analysis

What does Neuland Laboratories do? Neuland Laboratories Ltd, headquartered in Hyderabad, India, operates in the Pharmaceuticals sector within the Health Care industry. The company manufactures and exports bulk pharmaceutical ingredients and intermediates for the generics industry, serving both domestic and international markets. With 1,573 employees, Neuland provides active pharmaceutical ingredients (APIs) and end-to-end chemistry solutions, including custom manufacturing services for generic drug substances and advanced intermediates across clinical and commercial stages. Its business is structured into two verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Neuland Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuland Laboratories stock

Current Assets of Neuland Laboratories is 9.42 B INR in 2026.

Current Assets of Neuland Laboratories changed from 11.77 B INR to 9.42 B INR, representing a -19.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Neuland Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Neuland Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Neuland Laboratories

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Neuland Laboratories